MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$1,443K
Net Income
-$6,266K
Net Profit Margin
-434.23%
EPS
-$2.09
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Total revenues
1,443
1,100
901
1,302
Cost of revenues
812
700
708
884
Research and development
0
-
0*
0
Gain on sale of intangible assets
0
0
0
0
Impairment of property and equipment
-
-
0*
0
Change in fair value of contingent consideration
0
0
0
0
Selling, general and administrative
1,127
1,179
1,570
1,570
Total operating expenses
1,939
1,879
2,278
2,454
(loss) income from continuing operations
-496
-779
-1,377
-1,152
Interest income
2
5
-2
7
Credit loss
0
-
1,380*
-257
Other (gain) income, net
-2,781
-1,504
-1,844*
1,698
Loss on january 2026 inducement offer
0
-2,877
-
-
Valuation loss on june 2026 pipe
5,423
-
-
-
Change in fair value of common stock warrant and option liabilities
3,083
1,191
510
560
Net loss from continuing operations before income taxes
-
-
-1,334*
-
Income tax expense
-
-
2*
-
Net loss from continuing operations
-
-
-1,336
856
Net loss from discontinued operations
-
-
0
0
Issuance and offering costs
651
421
-
-
Net (loss) income from continuing operations
-6,266
-4,385
-1,336
856
Basic EPS
-2.09
-2.11
-0.974
0.63
Diluted EPS
-2.09
-2.11
-0.977
0.62
Basic Average Shares
2,992,555
2,082,887
1,371,936
1,367,192
Diluted Average Shares
2,992,555
2,082,887
1,367,106
1,371,879
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Net (loss) income
from continuing...
-$6,266K
(-40.56%↓ Y/Y)
Change in fair value of
common stock warrant...
$3,083K
(662.59%↑ Y/Y)
Interest income
$2K
(-77.78%↓ Y/Y)
Valuation loss on june 2026
pipe
$5,423K
Other (gain) income,
net
-$2,781K
(-359.66%↓ Y/Y)
Issuance and offering
costs
$651K
(loss) income from
continuing operations
-$496K
(1.00%↑ Y/Y)
Total revenues
$1,443K
(-0.82%↓ Y/Y)
Total operating
expenses
$1,939K
(-0.87%↓ Y/Y)
Selling, general and
administrative
$1,127K
(-46.91%↓ Y/Y)
Cost of revenues
$812K
(-1.46%↓ Y/Y)
Buy us a coffee
Arcadia Biosciences, Inc. (RKDA)
Arcadia Biosciences, Inc. (RKDA)